Khanh D. Vu, MD, FACP
Department of General Internal Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Professor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1999 | The University of Texas Medical School at Houston, Houston, Texas, US, Internal Medicine, Doctor of Medicine |
| 1995 | The University of Dallas, Irving, Texas, US, Biology, Bachelor of Science |
Postgraduate Training
| 2021-2022 | Physician Power User, Epic, University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2016-2018 | Fundamentals of Quality Improvement, MDACC Quality College, Houston, Texas |
| 2011-2011 | Professional Development, Mid Career Women Faculty Professional Development Seminar, Association of American Medical Colleges, Austin, Texas |
| 1999-2002 | Residency, The University of Texas Health Science Center at Houston, Houston, Texas |
Licenses & Certifications
| 2002 | Internal Medicine |
| 2002 | Texas Medical Board |
Experience & Service
Faculty Academic Appointments
Associate Professor, Baylor College of Medicine, Houston, TX, 2016 - 2019
Associate Professor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2022
Assistant Professor, General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, 2004 - 2011
Instructor, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2002 - 2004
Administrative Appointments/Responsibilities
Section Chief, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2026 - Present
Clinical Deputy Chair, General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Chair, Medical Record Committee, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2024 - Present
Vice Chair, Medical Record Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - 2024
Associate Medical Director, PeriOperative Evaluation & Management (POEM) Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Extramural Institutional Committee Activities
Member, Executive Committee of the Medical Staff, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Clinical Effectiveness Glycemic Management Work Group, The University of Texas MD Anderson Cancer Center, 2021 - 2021
Member, SGLT2-Inhibitor Work Group, The University of Texas MD Anderson Cancer Center, 2021 - Present
Member, Medical Record Committee - Generic Provider Encounters Work Group, The University of Texas MD Anderson Cancer Center, 2020
Member, AMA Evaluation and Management Change Subcommittee, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Member, Perioperative Assessment and Management in COVID Era Work Group, The University of Texas MD Anderson Cancer Center, 2020 - 2021
Member, Ambulatory Informatics Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, QAPI Glycemic Management of High-Risk DM Patient Having Outpatient Procedure Work Group, The University of Texas MD Anderson Cancer Center, 2020 - 2020
Member, Sugar Initiative Work Group, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Acute Care Clinic Subcommittee, The University of Texas MD Anderson Cancer Center, 2019 - 2020
Member, Medical Records Committee, The University of Texas MD Anderson Cancer Center, 2019 - Present
Chairman, Division of Internal Medicine Grand Rounds Planning Committee, The University of Texas MD Anderson Cancer Center, 2019 - 2023
Member, Clinical Effectiveness Neutropenic Fever Work Group, The University of Texas MD Anderson Cancer Center, 2019 - 2024
Officer, Electronic Health Record (EHR) Provider Officer Committee - Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, Electronic Health Record (EHR) Provider Experience Subcommittee, The University of Texas MD Anderson Cancer Center, 2018
Member, Sepsis Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2013
Member, Medical Practice Committee, The University of Texas MD Anderson Cancer Center, 2009 - 2025
Member, Division of Internal Medicine Grand Rounds Planning Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2025
Member, Clinical Research Committee CRC III, The University of Texas MD Anderson Cancer Center, 2006 - 2007
Member, Internal Medicine Center Steering Committee, The University of Texas MD Anderson Cancer Center, 2006
Member, Clinical Research Committee CRC II, The University of Texas MD Anderson Cancer Center, 2005 - 2006
Member, Performance Improvement Lean Project in the Internal Medicine Center, The University of Texas MD Anderson Cancer Center, 2005 - 2006
Member, Leukemia Research Support Committee, The University of Texas MD Anderson Cancer Center, 2003 - 2005
Member, Clinical Research Committee CRC I, The University of Texas MD Anderson Cancer Center, 2003 - 2005
Honors & Awards
| 2015 | Texas Chapter of the ACP Decade of Service Award, American College of Physicians |
| 2009 | Elected, Fellowship in the American College of Physicians, American College of Physicians |
| 2004 | Excellent Protocol Review Award, Clinical Research, The University of Texas MD Anderson Cancer Center |
| 1995 | Cum Laude, The University of Dallas |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. Trends in Patient Satisfaction Survey Scores Before and After the Implementation of a Surgical Co-Management Program in a Cancer Center. Poster. Houston, Texas, US.
- 2024. Perioperative Risk Assessment. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2023. Sense of Humor and Burnout in Physicians. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2022. Perioperative Risk Assessment Models. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2021. Perioperative Medical Evaluation. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2021. Neutropenic Fever. Conference. University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2018. Perioperative Medicine: 2018 Updates. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2017. ACP Internal Medicine Meeting Update in Internal Medicine: Evidence Published in 2016. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2017. Perioperative Medicine Update. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2014. Intervention to Promote Physician Well-being, Job Satisfaction and Professionalism. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2014. Work-life Balance. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2011. Venothromboembolism in Acute Leukemia Patients. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2009. Venothromboembolism in Acute Leukemia Patients. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2009. The Impacts of Anti-diabetic Medications on the Clinical Outcomes of Hyperglycemic ALL Patients. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
National Presentations
- 2022. Surgical Universal euGlycemic Attainment During Recovery (SUGAR) Initiative: Sweet Results Through Quality Improvement. Conference. Annual Meeting on Women's Cancer. Phoenix, AZ, US.
- 2021. Surgical Universal Euglycemic Attainment During Recovery (SUGAR Initiative): Sweet Results Through Standardization. Virtual Abstract Poster Presentation. Conference. 2021 ACS Quality and Safety Conference. Virtual Abstract Poster, US.
- 2021. Surgical Universal Euglycemic Attainment During Recovery (SUGAR Initiative): Sweet Results Through Standardization. Virtual Storyboard Presentation. Conference. 2021 IHI Patient Safety Conference. Virtual Storyboard, US.
- 2019. Cancer-related Challenges in the Inpatient Rehabiliation Setting. Invited. American Academy of Physical Medicine and Rehabilitation's (AAPM&R). San Antonio, TX, US.
- 2008. Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy for Acute Lymphocytic Leukemia. Poster Presentation. Conference. ASH Annual Conference. San Francisco, CA, US.
- 2007. Prevalence of hyperglycemia and obesity in patients with newly diagnosed acute lymphoblastic leukemia (ALL). Poster Presentation. Conference. ADA Annual Conference. Chicago, IL, US.
International Presentations
- 2025. Developing a surgical co-management program in a comprehensive cancer center. Poster. MASCC Annual Conferrence. Seattle, US.
- 2024. A review showing postoperative glucose values were reduced through standardizing the screening and management of surgical patients with diabetes. Poster. Annual Global Meeting of the International Gynecologic Cancer Society. Dublin, IE.
- 2017. Association of Nutritional Parameters and Survival in Parental Nutrition Supported Gastrointestinal Cancer Patients. Poster Presentation. Conference. ASCO Annual Conference. Chicago, US.
- 2015. Total Parental Nutrition (TPN) Utilization in a Large Cancer Center. Poster Presentation. Conference. MASCC Annual Conference. Copenhagen, DK.
- 2011. Prevalence of Venous Thromboembolism (VTE) Among Adult Patients (pts) With Acute Leukemia (AL) Prior To Treatment. Poster Presentation. Conference. ASCO Annual Conference. Chicago, US.
- 2009. Occurrence of venothromboembolism (VTE) in patients (pts with acute lymphocytic leukemia (ALL), Burkitt's leukemia/lymphoma (BL), or lymphoblastic leukemia (LL). Poster Presentation. Conference. ASCO Annual COnference. Orlando, US.
Selected Publications
Peer-Reviewed Articles
- Taylor, JS, Fellman, B, Cain, K, Iniesta-Donate, M, Earles, T, Harris, M, James, DA, Siebel, C, Lasala, J, Mena, GE, Raty, S, Popovich, SM, Vu, KD, Thosani, S, Best, CJ, Schmeler, KM, Ramirez, PT, Meyer, LA. Glycemic control to improve post-operative outcomes in patients with type 2 diabetes mellitus. International Journal of Gynecological Cancer 35(1), 2025. e-Pub 2025. PMID: 39878292.
- Taylor JS, Fellman BM, Raty S, Lasala J, Iniesta MD, Cain KE, Horner AA, Bruno M, Folloder JP, Knippel SL, Khanh V, Popovich S, Katz MHG, Best C, Thosani S. Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center. Ann Surg Oncol 31(5):3017-3023, 2024. e-Pub 2024. PMID: 38347330.
- Liu W, Qdaisat A, Lee E, Yeung J, Vu K, Lin JZ, Canada T, Zhou S, Cohen L, Bruera E, Yeung SJ. The association between weight stability and parenteral nutrition characteristics and survival in patients with colorectal cancer. Gastroenterol Rep (Oxf) 7(6):419-425. doi: 10.1093/gastro/goz021(6):419-425, 2019. e-Pub 2019. PMID: 31857903.
- Luong NV, Kroll MH, Vu K. Recurrence of Venous Thromboembolism Among Adult Acute Leukemia Patients Treated at the University of Texas MD Anderson Cancer Center: Incidence and Risk Factors. Thromb Res 156:14-19, 2017. e-Pub 2017. PMID: 28577388.
- Vu K, Luong NV, Hubbard J, Zalpour A, Faderl S, Thomas DA, Yang D, Kantarjian H, Kroll MH. A retrospective of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center. Cancer Med 4(1):27-35, 2015. e-Pub 2015. PMID: 25487644.
- Lu H, Pundole X, Vu K. Baseline characteristics predictive of malignancy among patients presenting with lymphadenopathy: A cancer center experience. CCIJ 2(4):325-29, 2013. e-Pub 2013.
- Vu K, Busaidy N, Cabanillas ME, Konopleva M, Faderl S, Thomas DA, O'Brien S, Broglio K, Ensor J, Escalante C, Andreeff M, Kantarjian H, Lavis V, Yeung SC. A randomized controlled trial of an intensive insulin regimen in patients with Accute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk 12(5):355-362, 2012. e-Pub 2012. PMID: 22658895.
- Verma D, Kantarjian H, Faderl S, O'Brien S, Pierce S, Vu K, Freireich E, Keating M, Cortes J, Ravandi F. Late relapses in acute myeloid leukemia: analysis of characteristics and outcome. Leuk Lymphoma 51(5):778-782, 2010. e-Pub 2010. PMID: 20196624.
- Dougherty PM, Cata JP, Burton AW, Vu K, Weng HR. Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain. J Pain Symptom Manage 33(2):166-79, 2007. e-Pub 2007. PMID: 17280922.
- Weiser MA, Cabanillas M, Vu K, Tamm EP, Wallace MJ, Escalante CP, Bresalier RS. Diagnostic evaluation of patients with a high suspicion of malignancy: comorbidities and clinical predictors of cancer. Am J Med Sci 330(1):11-8, 2005. e-Pub 2005. PMID: 16020994.
Abstracts
- Taylor JS, Fellman B, Cain KE, Iniesta MD, Earles T, Harris M, James D, Siebel C, Lasala J, Mena G, Raty S, Popovich S, Vu K, Thosani S, Best C, Schmeler KM, Ramirez PT, Meyer LA. Surgical universal euglycemic attainment during recovery (SUGAR) initiative: Sweet results through quality improvement (286). 2022 Society of Gynecologic Oncology (SGO) Annual Meeting, 2022.
- Lu H, Pundole X, Vu K. Diagnostic Predictors and Clinical Outcomes in Patients Presenting Solely with Lymphadenopathy. 2012 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting, 2012. e-Pub 2012.
- Luong NV, Kroll M, Faderl S, Yang D, Zalpour A, Nguyen KT, Verma D, Borthakur H, Kantarjian H, Vu K. Venothromboembolism (VTE) in patients (pts) with acute myelogenous leukemia (AML). J Clin Oncol 28(15(S)):674, 2010. e-Pub 2010.
- Mattiuzzi G, Lahoti A, Salahudeen A, Ravandi F, Cortes J, Vu K, Kantarjian H. An assessment of the RIFLE criteria for acute kidney injury (AKI) and mortality in patients (Pts) with acute myelogenous leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS). Blood 114(22):419-420, 2009. e-Pub 2009.
- Luong NV, Kantarjian HM, Faderl SH, Thomas DA, Vu K. Occurrence of venothromboembolism (VTE) in patients (pts) with acute lymphocytic leukemia (ALL), Burkitt's leukemia/lymphoma (BL), or lymphoblastic leukemia (LL). J Clin Oncol 27(15S):370, 2009. e-Pub 2009.
- Verma D, Faderl S, O'Brien S, Pierce S, Cortes J, Vu K, Freireich E, Keating MJ, Kantarjian HM, Ravandi F. Late relapses in acute myelogenous leukemia: Analysis of characteristics and outcome. Blood 112(11):350, 2008. e-Pub 2008.
- Vu K, S-C Y, Thomas DA, Faderl S, Konopleva M, Busaidy N, Cabanillas M, Verma D, Escalante C, O'Brien S, Lavis V, Kantarjian H, Weiser MA. Effect of tight control of blood glucose during hyper-CVAD chemotherapy for acute lymphocytic leukemia. Blood 112(11):336, 2008. e-Pub 2008.
- Vu K, Lavis V, Strom S, Faderl S, Konopleva M, Thomas D, Gruschkus S, Andreeff M, Kantarjian H. Hyperglycemia and obesity in patients (pts) with acute lymphoblastic leukemia (ALL): Association with prevalence, response, and survival. Journal of Clinical Onocology DOI: 10.1200/jco.2007.25.18_suppl.7074, 2007. e-Pub 2007.
- Faderl S, Thomas DA, Ravandi F, Garcia-Manero G, Beran M, Rytting M, Koller CA, Verstovsek S, Borthakur G, Andreeff M, Kornblau S, O'Brien S, Vu K, Kwari M. Intensification of Hyper-CVAD with L-Asparaginase, Vincristine, and Dexamethasone ("augmented Hyper-CVAD") has activity in adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL). Blood 110(11):149b, 2007. e-Pub 2007.
- Vu K, Hubbard JC, Lin E, Faderl SH, Cortes JE, O'Brien SM, Kantarjian HM, Thomas DA. Venothromboembolism (VTE) in patients (pts) with acute lymphocytic leukemia (ALL), Burkitt's leukemia/lymphoma (BL) or lymphoblastic lymphoma (LL). Blood 110(11):152-153b, 2007. e-Pub 2007.
- Vu K, Strom, S, Konopleva, M, Thomas, DA, Faderl, SH, Hubbard, JC, Andreeff, M, Kantarjian, H, Lavis, VR. Prevalence of Hyperglycemia and Obesity in Patients (pts) with Newly Diagnosed Acute Lymphoblastic Leukemia (ALL). Diabetes 56, 2007. e-Pub 2007.
- Vu K, Thomas DA, Hubbard JC, Faderl S, Cortes J, Cabanillas ME, Garcia-Manero G, O'Brien SM, Kantarjian HM. Incidence of venothromboembolism (VTE) in patients (pts) with acute lymphocytic leukemia (ALL), Burkitt's leukemia/lymphoma (BL) or lymphoblastic leukemia (LL). Blood 108(11), 2006. e-Pub 2006.
- Faderl S, Thomas DA, Garcia-Manero G, Ravandi F, Beran M, Rytting M, Koller CA, Verstovsek S, Borthakur G, Andreeff M, Kornblau S, Vu K, Jarmon R, Kantarjian HMK. Augmented hyper-CVAD in acute lymphoblastic leukemia and vincristine in adult ALL salvage: The MDACC experience with intensified L-asparaginase and vincristine in adult ALL salvage. Blood 106(11):523a, 2005. e-Pub 2005.
- Cabanillas, ME, Mattiuzzi G, Thomas D, Vu K, Ossa G, Garcia-Manero G, Cortes J, Giles F, O’Brien S, Kantarjian H. Invasive fungal infections (IFI) in patients (pts) receiving hyper-CVAD. J Clin Oncol 23:6727, 2004. e-Pub 2004.
- Quintas-Cardama, A, Kantarjian H, O’Brien S, Vu K, Garcia-Manero G, Giles F, Rios MB, Talpaz M, Cortes J. Administration of G-CSF (Filgrastim, NeupogenTM) for imatinib mesylate (GleevecTM)-induced neutropenia in chronic phase chronic myeloid leukemia (CML) patients (pts) is safe and facilitates the achievement of cytogenetic responses. Blood 102:906a, 2003. e-Pub 2003.
- Vu KD. A review showing postoperative glucose values were reduced through standardizing the screening and management of surgical patients with diabetes. International Gynecologic Cancer Society.
- Misoi M, Vu KD, Magnabosco L, Escalante C, Le J, Gonzalez M, Song J, Akorede A, Bassaragh A, Reeni L, Soones T, Rukundo I, Bree K, Mantaring C. Developing a Surgical Co-Management Program in a Comprehensive Cancer Center.
Book Chapters
- Gao S, Vu K, Gushiken F, Thuy Nguyen AKT. Hematologic Emergencies. In: Oncologic Emergencies, 2016.
- Vu K. Febrile Neutropenia in Acute Leukemia Patients. In: Rehabilitation Medicine Quick Reference, 2014.
Patient Reviews
CV information above last modified July 22, 2026